Trulieve Cannabis Corp. TRUL TCNNF posted Thursday its first-quarter financial results with record quarterly revenue for $193.8 million, up by 102% from the same period in 2020. This marks the company’s 13th consecutive quarter of profitability.
The Tallahassee, Florida-headquartered company achieved a positive adjusted EBITDA of $90.8 million, which compares to $81.4 million in the previous quarter. The gross margin was 70%, compared to 77% in the first quarter of last year.
The Analyst
Cantor Fitzgerald’s Pablo Zuanic kept an “Overweight” rating on Trulieve’s stock with a price target of $76.
The Thesis
Trulieve’s quarterly sales were below Cantor’s estimates, but 3% above FactSet consensus, explained Zuanic in a Thursday note.
The analyst believes that the company’s sales in Florida jumped 11% in spite of high competition in the market, and thanks to the accelerated patient number growth. The company should experience even more upside in Florida through its “aggressive store expansion,” and have 100 stores by the end of the year. At the moment it has 82 stores.
Trulieve’s management team noted that the accelerated patient growth in Florida actually caught the company unprepared in terms of flower capacity in the first quarter. That’s why now it intends to add more than 200k sq. ft. of capacity in the state, wrote Zuanic.
“Continued growth in Florida, contribution from the growing Pennsylvania market, and the Massachusetts ramp up mid-year should drive growth in the year ahead.”
According to Zuanic, the Harvest Health & Recreation Inc. HARV HRVSF merger should also bring revenue and cost synergies, even though he still questions the strategic merits of the deal.
“We stay Overweight, on valuation, growth potential, and the strength of the Florida franchise.”
The stock brings an important long-term upside potential, concluded Zuanic.
The Price Action
Trulieve’s shares were trading 0.73% lower at $39.29 at the time of writing.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!